Statistiques de base
| CIK | 1404356 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Canopus BioPharma Incorporated
SEC Filings (Chronological Order)
Cette page fournit une liste complète et chronologique des documents déposés auprès de la SEC, à l'exclusion des documents relatifs à la participation que nous fournissons ailleurs.
| September 12, 2023 |
CBIA / Blue Heaven Coffee Inc / Mango Innovation LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Canopus Biopharma, Inc. dba Blue Heaven Coffee, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 628635104 (CUSIP Number) September, 11, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| September 11, 2023 |
Blue Heaven Coffee, Inc. 304 South Jones Boulevard, Unit 8925 Las Vegas, Nevada 89107 Blue Heaven Coffee, Inc. 304 South Jones Boulevard, Unit 8925 Las Vegas, Nevada 89107 September 11, 2023 VIA EDGAR Scott Anderegg Office of Trade & Services Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Form 1-A POS Filed August 17, 2023 File No. 024-12248 Request for Withdrawal Pursuant to Rule 477 of Post-Qualification Amend |
|
| August 17, 2023 |
EXHIBIT 12.1 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 August 17, 2023 Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporatio |
|
| August 17, 2023 |
Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock File No. 024-12248 OFFERING CIRCULAR Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 2 (the “PQA2”) amends the Offering Circular of Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation, dated May 11, 2023, as qualified on May 22, 2023, and Post-Qualification Amendmen |
|
| August 15, 2023 |
CBIA / Blue Heaven Coffee Inc / Mango Innovation LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Canopus Biopharma, Inc. dba Blue Heaven Coffee, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 628635104 (CUSIP Number) August, 09, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| August 9, 2023 |
Post-Qualification Offering Circular Amendment No. 1 Supplement Dated August 9, 2023 Filed Pursuant to Rule 253(g)(2) File No. 024-12248 Post-Qualification Offering Circular Amendment No. 1 Supplement Dated August 9, 2023 A Post-Qualification Amendment No. 1 to Offering Statement (the “PQA#1”) of Blue Heaven Coffee, Inc. pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission (“SEC”). The PQA#1 was Qualified on July 21, 2023 |
|
| July 24, 2023 |
Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock Filed Pursuant to Rule 253(g)(1) File No. 024-12248 OFFERING CIRCULAR Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular of Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation, dated May 11, 2023, as qualified on May 22, 2023, |
|
| July 20, 2023 |
Blue Heaven Coffee, Inc. 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 Blue Heaven Coffee, Inc. 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 July 20, 2023 VIA EDGAR Nicholas Nalbantian Office of Trade and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Blue Heaven Coffee, Inc. Post-Qualification Amendment No. 1 to Offering Statement on Form 1-A Filed July 12, 2023 (the “Post-Qual |
|
| July 12, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 July 12, 2023 EXHIBIT 12.1 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 July 12, 2023 Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation |
|
| July 12, 2023 |
Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock File No. 024-12248 OFFERING CIRCULAR Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 1,200,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular of Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation, dated May 11, 2023, as qualified on May 22, 2023, and as may be amended and supple |
|
| June 16, 2023 |
CBIA / Blue Heaven Coffee Inc / Mango Innovation LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Canopus Biopharma, Inc. dba Blue Heaven Coffee, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 628635104 (CUSIP Number) May 24, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| May 24, 2023 |
Offering Circular Supplement Dated May 23, 2023 Filed Pursuant to Rule 253(g)(2) File No. 024-12248 Offering Circular Supplement Dated May 23, 2023 An Offering Statement (the “Offering Statement”) filed by Blue Heaven Coffee, Inc. pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission (“SEC”). The Offering Statement was Qualified on May 22, 2023. This Offering Circular Supplement covers |
|
| May 23, 2023 |
Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 200,000,000 Shares of Common Stock Filed Pursuant to Rule 253(g)(1) File No. 024-12248 OFFERING CIRCULAR Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 200,000,000 Shares of Common Stock By this Offering Circular, Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation, is offering for sale a maximum of 200,000,000 shares of its common stock (the “Offered Shares”), at a fixed price of $0.02 per |
|
| May 18, 2023 |
Blue Heaven Coffee, Inc. 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 Blue Heaven Coffee, Inc. 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 May 18, 2023 VIA EDGAR Nicholas Nalbantian Office of Trade and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Blue Heaven Coffee, Inc. Offering Statement on Form 1-A Commission File No. 024-12248 Dear Mr. Nalbantian: On behalf of the Compan |
|
| May 11, 2023 |
EXHIBIT 2.1 |
|
| May 11, 2023 |
EXHIBIT 2.2 |
|
| May 11, 2023 |
EXHIBIT 4.1 SUBSCRIPTION AGREEMENT Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) NOTICE TO INVESTORS The securities of Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for a |
|
| May 11, 2023 |
Bylaws Canopus BioPharma, Inc. EXHIBIT 2.3 Bylaws of Canopus BioPharma, Inc. ARTICLE I — OFFICES 1.1 Principal Office. The principal office and place of business of Canopus BioPharma, Inc. (the “Corporation”) shall be at such location as may be determined from time to time by board of directors of the Corporation (the “Board of Directors”). 1.2 Other Offices. Other offices and places of business either within or without the Sta |
|
| May 11, 2023 |
EXHIBIT 3.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE S |
|
| May 11, 2023 |
File No. 024- As filed with the Securities and Exchange Commission on May 11, 2023 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated May 11, 2023 An offering statement pursuant to Regulation A relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”). Information contained in this Preliminary Offering Cir |
|
| May 11, 2023 |
EXHIBIT 6.1 |
|
| May 11, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 May 10, 2023 EXHIBIT 12.1 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 May 10, 2023 Blue Heaven Coffee, Inc. (formerly Canopus BioPharma, Inc.) 304 South Jones Boulevard Unit 8925 Las Vegas, Nevada 89107 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Blue Heaven Coffee, Inc., formerly Canopus BioPharma, Inc., a Nevada corporation ( |
|
| May 11, 2023 |
EXHIBIT 7.1 SHARE PURCHASE AGREEMENT This Share Purchase Agreement (the “Agreement”) is made and entered into effective as of March 21, 2023, by and between Canopus Biopharma, Inc., a Nevada corporation (“Purchaser”), and Justin De Four (“Seller”), the sole shareholder of Blue Heaven Coffee, Inc., an Ontario, Canada, corporation (“Acquired Corporation”). Buyer and Seller are the only Parties to th |
